MedTrace Logo

ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users

NCT01066780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2020-07-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect information about how the new sound-processing affects the ability to hear in everyday listening situations.

Conditions

  • Implant

Interventions

DEVICE

ClearVoice

ClearVoice is a sound processing strategy designed to improve listening ability in some challenging everyday listening environments for users of the Harmony® HiResolution® Bionic Ear System (Harmony®)

Sponsors & Collaborators

  • Advanced Bionics

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01066780 on ClinicalTrials.gov